Integra LifeSciences Holdings Corporation /
Acclarent, Inc.
Integra LifeSciences to buy Acclarent from Ethicon
What happened
Integra LifeSciences Holdings Corporation agreed to acquire Acclarent, Inc. from Ethicon, Inc. The transaction includes $275.0 million in cash, subject to customary purchase price adjustments, and a $5.0 million regulatory milestone payment.
Acclarent develops devices and technologies for ENT procedures. The transaction is expected to close by the second quarter of 2024.
The source
Everything on this page comes from the source below.
Integra LifeSciences to buy Acclarent from Ethicon
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Expected close
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly